Quality ManagementCommercialMedicare AdvantageJune 4, 2024

HEDIS measure tips — Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB)

Healthcare Effectiveness Data Information Set (HEDIS®) is a widely used set of performance measures developed and maintained by NCQA. These are used to drive improvement efforts surrounding best practices.

This HEDIS measure looks at the percentage of episodes for members ages 3 months and older with a diagnosis of acute bronchitis/ bronchiolitis that did not result in an antibiotic dispensing event July 1 of the year prior to the measurement year to June 30 of the measurement year.

Exclusions:

  • Members who use hospice services or elect to use a hospice benefit anytime during the measurement year
  • Members who die any time during the measurement year

Refer to attachment to view full details

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

Anthem Blue Cross and Blue Shield is the trade name of Rocky Mountain Hospital and Medical Service, Inc. HMO products underwritten by HMO Colorado, Inc., dba HMO Nevada. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CRCM-060745-24-SRS60745, MULTI-BCBS-CRCM-046194-23-CPN45671

ATTACHMENTS: HEDIS measure tips — Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) (pdf - 0.8mb)